mild&#32

2 trials

Sponsors

The Second Xiangya Hospital of CSU, The First Affiliated Hospital of Nanjing Medical University

Conditions

Novel Coronavirus Pneumonia (COVID-19)mild cognitive impairment

Early Phase 1

Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies

Active, not recruitingChiCTR2000030771

The Second Xiangya Hospital of CSUNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-03-01Updated: 2020-03-23

Cognitive Outcomes Prediction Evaluation (COPE) Study: Based on a Cohort of Chronic Kidney Disease Patients

Active, not recruitingChiCTR2000035328

The First Affiliated Hospital of Nanjing Medical Universitymild cognitive impairment

Start: 2020-11-01Updated: 2020-08-10